Ameritas Advisory Services’s Genmab GMAB Stock Holding History

Ameritas Advisory Services’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-72	Closed	-$2.21K	–	1406
2025 Q3	$2.21K	Sell	72 -28	-28%	-$682	﹤0.01%	1971
2025 Q2	$2.07K	Buy	+100	New	+$2.05K	﹤0.01%	2475
2023 Q2	–	Sell	-28	Closed	-$1.16K	–	1347
2023 Q1	$1.16K	Buy	+28	New	+$1.08K	﹤0.01%	2520

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameritas Advisory Services's GMAB Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Genmab (GMAB) in Q4 2025, closing a stake of 72 shares — an estimated $2.21K sold.

Ameritas Advisory Services first reported a position in GMAB in Q1 2023 and held it in 3 quarters. The position peaked at $2.21K in Q3 2025. 292 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

Ameritas Advisory Services reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
Ameritas Advisory Services sold 72 Genmab shares in Q4 2025, an estimated $2.21K.
Ameritas Advisory Services first reported a position in Genmab in Q1 2023 and held it in 3 quarters.
Ameritas Advisory Services's Genmab position peaked at $2.21K in Q3 2025.
292 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.